Printer Friendly
The Free Library
19,585,763 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biomet announces third quarter and nine month results.


WARSAW, Ind.--(BUSINESS WIRE)--March 18, 1997--Biomet, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BMET BMET Biomedical Engineering Technology
BMet Bachelor of Metallurgy
BMET Bio-Medical Equipment Repair Technician
) today reported record sales and earnings for its third quarter and nine months ended February 28, 1997. -0-

                      ($000's Except Per Share Data)

Third Quarter Ended February 28:

                                 1997        1996      Percent Change
Net sales                     $146,164    $133,469           10 %
Gross profit                    99,305      89,596           11
Operating income                41,067      35,393           16
Net income                      27,279      23,493           16
Earnings per share                 .24         .20           20

U.S. sales                    $106,007    $ 99,408            7 %
Foreign sales                   40,158      34,061           18

Reconstructive sales          $ 87,203    $ 80,997            8 %
EBI sales                       29,013      27,522            5
Other products                  29,948      24,950           20

Nine Months Ended February 28:

                                 1997        1996       Percent Change

Net sales                     $427,351    $393,742             9 %
Gross profit                   289,659     265,040             9
Operating income               116,852      99,290            18
Net income                      77,551      66,977            16
Earnings per share                 .68         .58            17

U.S. sales                    $314,406    $295,475             6 %
Foreign sales                  112,946      98,267            15

Reconstructive sales          $257,488    $238,071             8 %
EBI sales                       85,320      81,010             5
Other products                  84,543      74,661            13





Increases in sales and earnings for the third quarter of fiscal year 1997 as compared to the same period in fiscal year 1996 were principally attributable to the continued market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market
penetration - the act of entering into or through something; "the penetration of upper management by women"
 of the Company's primary and revision reconstructive re·con·struc·tive  
adj.
1. Relating to or characterized by reconstruction.

2. Serving to rebuild, restore, or correct the appearance and function of defective, damaged, or misshaped body structures or parts:
 devices in both the international and domestic markets. The Company's Maxim Total Knee and Alliance Hip Systems continued to capture market share in the domestic reconstructive market. In addition the Company is experiencing robust growth in the internal fixation internal fixation
n.
The stabilization of fractured bony parts by direct fixation to one another with surgical wires, screws, pins, or plates.
 market. EBI's growth was driven by increased sales of bone healing Bone healing or fracture healing is a proliferative physiological process, in which the body facilitates repair of Bone fractures. Physiology and process of healing  products.

Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by orthopedic orthopedic /or·tho·pe·dic/ (-pe´dik) pertaining to the correction of deformities of the musculoskeletal system; pertaining to orthopedics.  medical specialist in both surgical and non-surgical therapy, including reconstructive and trauma devices, electrical bone growth stimulators, orthopedic support devices, operating room operating room
n. Abbr. OR
A room equipped for performing surgical operations.
 supplies, powered surgical instruments A surgical instrument is a specially designed tool or device for performing specific actions of carrying out desired effects during a surgery or operation, such as modifying biological tissue, or to provide access or viewing it. , general surgical instruments, arthroscopy Arthroscopy Definition

Arthroscopy is the examination of a joint, specifically, the inside structures. The procedure is performed by inserting a specifically designed illuminated device into the joint through a small incision.
 products and craniomaxillofacial implants and instruments. Headquartered in Warsaw, Indiana Warsaw is a city in, and the county seat of, Kosciusko County, Indiana, United StatesGR6. The population was 12,415, as of the 2000 census.

Cradled between Winona Lake, Pike Lake and Center Lake, Warsaw is nicknamed "Lake City
, Biomet and its subsidiaries currently distribute products in approximately 100 countries.

For further information contact Kathy Waggener, Manager, Corporate Communications Corporate communications is the process of facilitating information and knowledge exchanges with internal and key external groups and individuals that have a direct relationship with an enterprise.  at (219) 267-6639. -0-
                     BIOMET, INC. - - QUARTER RESULTS

                 FOR THE PERIODS ENDED FEBRUARY  28, 1997
                              (in thousands)

                   Three Months                     Nine Months

                      Amount                           Amount

Net Sales           $146,164                         $427,351

Cost of Sales         46,859                          137,692
                    __________                       __________
Gross Profit          99,305                          289,659

S,G, & A              52,910                          154,900
 R & D                 5,328                           17,907
                    __________                       __________
Total S,G & A         58,238                          172,807
                    __________                       __________

Operating Income      41,067                          116,852

Other Income           2,354                            6,858
                    __________                       __________
Income Before         43,421                          123,710
   Taxes

Provision for
   Taxes              16,142                           46,159
                    __________                       __________
Net Income            27,279                           77,551
                    __________                       __________
                    __________                       __________

EPS                      .24                              .68





CONTACT: Biomet, Inc., Warsaw

Kathy Waggener, Manager, Corporate Communications

219/267-6639
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 18, 1997
Words:463
Previous Article:SBC raises quarterly cash dividend 4.1 percent to 44.75 cents; thirteenth consecutive annual increase.
Next Article:COVENTRY SIGNS DEFINITIVE AGREEMENT TO SELL MEDICAL OFFICES ASSOCIATED WITH ST. LOUIS HEALTH PLAN.
Topics:



Related Articles
Biomet announces second quarter and first half results.
Biomet announces record fiscal year results and cash dividend.
Biomet Announces Record First Quarter Results.
Biomet Announces Record Third Quarter and Nine Month Results.
Biomet Announces Record Fiscal Year Results and Cash Dividend.
Rapid Prototyping Provides Speed, Cost-Effective Castings.
Rapid prototyping provides speed, cost-effective castings. (Case history).
Biomet Announces Record Third Quarter Results and Expansion of Its Share Repurchase Program.
Biomet Announces Record Second Quarter Results, Expansion of Its Share Repurchase Program, and Key Management Promotions.
Biomet Announces Record Third Quarter Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles